Pitavastatin Market Size was valued at USD 537.1 Mn in 2023 and is predicted to reach USD 890.2 Mn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. The increasing awareness of preventive healthcare measures and the significance of managing cardiovascular risk factors are driving the demand for pitavastatin as a preventive medication. Opportunities exist to expand the global reach of the pitavastatin market, tap into emerging ma...
Report ID: 2421 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Global DTC Wellness Testing Market Size is valued at USD 973.30 Mn in 2023 and is predicted to reach USD 3,518.77 Mn by the year 2031 at a 17.79% CAGR during the forecast period for 2024-2031. The global market for (DTC) genetic testing encompasses regions where genetic testing services and products are directly marketed and sold to consumers, bypassing medical professionals or intermediaries. DTC genetic testing enables individuals to obtain ...
Report ID: 2317 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031 at a 19.20 % CAGR during the forecast period for 2023-2031. Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by comp...
Report ID: 1174 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Microbiome Diagnostics Market Size is valued at USD 154.9 Mn in 2023 and is predicted to reach USD 488.2 Mn by the year 2031 at a 15.6% CAGR during the forecast period for 2024-2031. Utilizing advanced genomic and bioinformatic techniques, these diagnostics can profile microbial DNA from samples (e.g., gut, skin, oral cavity) to understand the composition and function of the microbiome. Applications range from disease diagnosis and risk assess...
Report ID: 2398 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Alpha 1 Lung Disease Market Size is valued at USD 4.13 Billion in 2022 and is predicted to reach USD 19.93 Billion by the year 2031 at a 19.33% CAGR during the forecast period for 2023-2031. Alpha-1 Antitrypsin Deficiency is a genetic disorder in which the body does not make enough of a protein known as alpha-1 antitrypsin. This protein is very important for keeping the lungs safe from damage caused by inflammation. People who don't get enough...
Report ID: 2274 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Nucleic Acid Sample Preparation Market Size is valued at USD 2.89 Billion in 2023 and is predicted to reach USD 4.57 Billion by the year 2031 at a 6.10% CAGR during the forecast period for 2024-2031. Molecular biology relies on nucleic acid sample preparation to extract, purify, and concentrate DNA or RNA from blood, tissue, cell, and environmental samples. High-quality nucleic acids are essential for genetic and molecular analysis like PCR, N...
Report ID: 2386 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
The Swab And Viral Transport Medium Market Size is valued at 8.09 Billion in 2023 and is predicted to reach 13.16 Billion by the year 2031 at a 6.47 % CAGR during the forecast period for 2024-2031. Viral transport medium is used to collect, transport, maintain and store the clinical specimens containing viruses, chlamydia, mycoplasma or ureaplasma organisms. A viral skin swab is lightly rubbed against a visible skin lesion or vesicle and ...
Report ID: 1125 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
The Global Plant-Based API Market Size is predicted to witness a 7.49% CAGR during the forecast period for 2023-2031. Active Pharmaceutical Ingredients (APIs) and excipients are the two most essential components in the manufacture of medication. The API is the chemical from which the medication is created. In contrast, the excipient is a component that isn't the drug but works as a medium that allows the body to absorb the medicine, including la...
Report ID: 1715 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Combo IVD Market Size is valued at USD 550.12 Mn in 2023 and is predicted to reach USD 920.86 Mn by the year 2031 at a 6.84% CAGR during the forecast period for 2024-2031. Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are useful for detecting and monitoring a wide range of medical illnesses, including infectious disorders and autoimmune diseases. T...
Report ID: 2376 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Coagulation Factor Deficiency Market Size is valued at USD 5.50 Bn in 2023 and is predicted to reach USD 9.60 Bn by the year 2031 at a 7.36% CAGR during the forecast period for 2024-2031. Coagulation factor deficiency refers to a medical disorder characterized by an inadequate or malfunctioning of coagulation factors, which are proteins responsible for blood clotting. This can result in hemorrhagic diseases, manifesting as signs suc...
Report ID: 2163 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Pharmaceuticals